Category: Gastroenterology

May 09 2019

Isopropyl alcohol nasal inhalation for nausea in adults

Beadle et al. Ann Emerg Med 2016 Jul;68(1):1-9 e1.
Nasal inhalation of isopropyl alcohol provides clinically important relief from acute nausea, of at least a short duration, in community ambulatory patients

Permanent link to this article: https://evidencebasedmedicine.com.au/?p=1768

Jul 03 2017

Should PPIs be routinely co-prescribed with long-term NSAIDs?

Rostom et al. Cochrane database of systematic reviews 2002(4):CD002296.
Proton-pump inhibitors (PPIs) protect against the development of ulcers seen on endoscopy, in patients taking longer-term NSAIDs. Little data exists on clinical outcomes.

Permanent link to this article: https://evidencebasedmedicine.com.au/?p=1719

Dec 05 2016

Milk thistle for chronic hepatitis B

Rambaldi et al. Cochrane database Syst Rev 2007 Oct 17(4):CD003620
Milk thistle products cannot be recommended for chronic hepatitis B. Only limited research evidence of unclear/poor quality exists.

Permanent link to this article: https://evidencebasedmedicine.com.au/?p=1703

Mar 13 2015

Yoghurt to prevent antibiotic-associated diarrhoea in children

Fox MJ, et al. BMJ Open 2015;5(1): e006474
Probiotic yoghurt appears to reduce the incidence of diarrhoea in children receiving antibiotics in general practice settings.

Permanent link to this article: https://evidencebasedmedicine.com.au/?p=1658

May 24 2013

Is yoghurt helpful for antibiotic-associated diarrhoea?

Conway S, Hart A, Clark A, Harvey I. BJGP 2007; 57(545): 953-959
Yoghurt eaters in this study might have suffered less antibiotic-associated diarrhoea as compared to those who ate no yoghurt.

Permanent link to this article: https://evidencebasedmedicine.com.au/?p=1595

Apr 13 2011

Proton pump inhibitors with clopidogrel

van Boxel OS, et al. Cardiovascular and gastrointestinal outcomes in clopidogrel users on proton pump inhibitors: results of a large Dutch cohort study. Am J Gastroenterol 2010; 105: 2430–6
Concurrent proton pump inhibitors may increase the risk of cardiovascular outcomes in patients taking clopidogrel.

Permanent link to this article: https://evidencebasedmedicine.com.au/?p=1322

Jan 14 2011

Placebos for irritable bowel syndrome

Kaptchuk TJ, et al. Placebos without deception: a randomized controlled trial in irritable bowel syndrome. PLoS ONE 2010; 5(12): e15591
The positive results widely reported for placebo pills in consenting patients with irritable bowel syndrome are likely invalid due to serious methodological limitations in the study.

Permanent link to this article: https://evidencebasedmedicine.com.au/?p=749